WEST PHARM.SVCS DL-,25/ US9553061055 /
| 25/07/2024 11:32:05 | Chg. +2.000 | Volume | Bid19:27:47 | Ask19:27:47 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 295.500EUR | +0.68% | 65 Turnover: 19,207.500 |
268.100Bid Size: 2,000 | 272.400Ask Size: 2,000 | 19.31 bill.EUR | - | - |
Business description
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia.
Management board & Supervisory board
| CEO |
|---|
| Eric M. Green |
| Management board |
| Bernard J. Birkett, Annette F. Favorite, Chris Ryan, Cindy Reiss-Clark, Dr. Quintin Lai, Kimberly Banks MacKay, Silji Abraham, Kathy dePadua |
| Supervisory board |
| Eric M. Green, Deborah Keller, Douglas A. Michels, Mark Buthman, Molly E. Joseph, Myla Lai-Goldman, M.D., Paolo Pucci, Robert Friel, Thomas W. Hofmann, Stephen Lockhart, William F. Feehery |
Company data
| Name: | West Pharmaceutical Services Inc. |
| Address: | 530 Herman O. West Drive,Exton, PA 19341-0645, USA |
| Phone: | +1-610-594-2900 |
| Fax: | - |
| E-mail: | west.pharmaceutical....rma.com west.pharmaceutical.services@westpharma.com |
| Internet: | www.westpharma.com |
| Industry: | Healthcare |
| Sector: | Pharmaceutical Industry |
| Sub sector: | Pharmaceuticals |
| End of financial year: | 31/12 |
| Free Float: | 67.50% |
| IPO date: | - |
Investor relations
| Name: | Dr. Quintin Lai |
| IR phone: | +1-610-594-3318 |
| IR Fax: | - |
| IR e-mail: | Quintin.Lai@westpharma.com |
Company calendar
| CW 30 | 25/07/2024 Interim Report 2nd Quarter/6 Months |
| CW 31 | 31/07/2024 Ex-Dividend |
| CW 31 | 31/07/2024 Record Date |
| CW 32 | 07/08/2024 Dividend Payment |
Main Shareholders
| Others | 52.01% | |
| Vanguard Group Inc | 12.12% | |
| Blackrock Inc. | 10.79% | |
| Bank Of New York Mellon Corporation | 4.59% | |
| State Street Corporation | 4.43% | |
| Price (T.Rowe) Associates Inc | 3.84% | |
| Apg Asset Management N.V. | 3.06% | |
| Franklin Resources, Inc. | 2.94% | |
| T. Rowe Price Investment Management, Inc. | 2.34% | |
| Others | 3.88% |
